Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
legislation
Biotech
Biotechs lobby for their identity as drug pricing reforms set in
The IRA's drug pricing reforms have sent waves through biopharma, with executives arguing the legislation stands to stymie innovative new medicines.
Max Bayer
,
Gabrielle Masson
Jun 28, 2023 7:00am
Greenwood to step down as CEO of BIO after 2020 election
Oct 9, 2019 7:45am
Senate approves $2B boost for NIH in $850B+ spending bill
Aug 24, 2018 10:07am
In defiance of Trump, Senate poised to boost NIH funding—again
Aug 21, 2018 10:45am
Right-to-try is designed to weaken the FDA, law’s author says
Jun 1, 2018 9:50am
Message to Trump: Alnylam CEO proud to be a ‘shitholer’
Jan 15, 2018 10:17am
